未经证实:在接受肝切除术的患者中观察到胆结石的风险增加。本研究试图分析肝切除术后胆结石的危险因素。
UNASSIGNED:从2013年1月至2016年12月,对1,452例符合条件的肝切除术患者的临床数据进行了连续审查。根据影像,包括胆囊超声,计算机断层扫描,和磁共振成像,将所有患者分为胆结石组和非胆结石组。进行单变量和多变量逻辑回归分析,以选择与肝切除术后患者胆结石形成相关的指标。
未经证实:在纳入患者的总样本中,有341例胆结石患者和1,147例无胆结石患者。胆结石发生率为23.5%(341/1,452)。原发性肝癌组胆结石发生率高于良性肝肿瘤组(25.7%vs.18.9%,P=0.004)。单因素和多因素Logistic回归分析显示,女性性别,高体重指数,位于S5的肿瘤和严重的术后并发症是肝良性肿瘤患者肝切除术后胆结石的相关因素。此外,Child-PughB,低白蛋白,肝硬化,肝切除术后复发的肝动脉化疗栓塞(TACE)是原发性肝癌患者胆结石的相关因素。
未经证实:肝切除术增加良性或恶性肝肿瘤胆结石的风险,特别是当肿瘤位于S5时。TACE进一步增长了胆结石患者术后复发的风险。
UNASSIGNED: An increased risk of gallstones has been observed in patients undergoing hepatectomy. This
study attempted to analyze the risk factors for gallstones after hepatectomy.
UNASSIGNED: From January 2013 to December 2016, clinical data of 1,452 eligible patients who underwent hepatectomy were consecutively reviewed. According to the imaging, including gallbladder ultrasound, computerized tomography, and magnetic resonance imaging, all patients were divided into the gallstone group and the nongallstone group. Univariate and multivariate logistic regression analyses were performed to select indicators associated with gallstone formation among patients after hepatectomy.
UNASSIGNED: In the total sample of included patients, there were 341 patients with gallstones and 1,147 patients without gallstones. The incidence of gallstones was 23.5% (341/1,452). The incidence of gallstones in the primary liver cancer group was higher than that in the benign liver tumor group (25.7% vs. 18.9%, P = 0.004). Univariate and multivariate logistic regression analyses showed that female gender, high body mass index, tumor located in S5, and severe postoperative complication were factors related to gallstones in patients with benign liver tumors after hepatectomy. In addition, Child-Pugh B, low albumin, liver cirrhosis, and transcatheter arterial chemoembolization (TACE) after recurrence were factors related to gallstones in patients with primary liver cancer after hepatectomy.
UNASSIGNED: Hepatectomy increased the risk of gallstones in benign or malignant liver tumors, especially when the tumor was located in S5. TACE further increased the risk of gallstones in patients with postoperative recurrence.